Uniphage Inc.

Uniphage is developing the first-ever safe, efficient, ultra-targeted (and even organic) antifungal and antibacterial drugs for plants. They use cutting-edge AI to select safe bacterial and fungal viruses to eliminate target pathogens using only the pathogen’s genomic information. Uniphage has built a deep learning powered platform technology to predict 100X faster than previously possible bacterial viral-host interactions and identified safe viruses against a range of bacterial targets.

Uniphage has received extensive non-dilutive funding and is supported by MassChallenge, IBM, Thiel Foundation, iGEM, the National University of Singapore, and other amazing organizations and individuals.